The price of a box of Ocitinib is about RMB 5,580. Currently, Ocitinib is a targeted drug for the treatment of lung cancer, which is used to treat locally advanced, metastatic non-small cell lung cancer and advanced malignant diseases that cannot be treated surgically, and is an important type of third-generation oral chemotargeted drug. It has been included in the reimbursement scope of China’s medical insurance, but due to the different reimbursement ratio of medical insurance in each region, the specific price may vary in different regions. For the specific price of the relevant drugs, it is recommended to visit a regular hospital for examination and detailed consultation with the local hospital after the specific cause of the disease is diagnosed.